PathOS: A decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories

Genome Medicine

Volumn 9, Issue 1, 2017, Pages

  Doig, Kenneth D ^a,b   Fellowes, Andrew ^a   Bell, Anthony H ^a   Seleznev, Andrei ^a   Ma, David ^a   Ellul, Jason ^a   Li, Jason ^a   Doyle, Maria A ^a   Thompson, Ella R ^a,b   Kumar, Amit ^a,c,d   Lara, Luis ^a,b   Vedururu, Ravikiran ^a   Reid, Gareth ^a   Conway, Thomas ^a   Papenfuss, Anthony T ^a,b,c   Fox, Stephen B ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; CANCER DIAGNOSIS; CLINICAL LABORATORY; DECISION SUPPORT SYSTEM; DIGITAL FILTERING; GENE FREQUENCY; HIGH THROUGHPUT SEQUENCING; NEXT GENERATION SEQUENCING; ONLINE SYSTEM; SOFTWARE; WEB BROWSER; CLINICAL LABORATORY SERVICE; DNA SEQUENCE; GENETICS; GENOMICS; HUMAN; NEOPLASMS; PERSONALIZED MEDICINE; PROCEDURES;

CLINICAL LABORATORY SERVICES; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; PRECISION MEDICINE; SEQUENCE ANALYSIS, DNA; SOFTWARE;

EID: 85018588544     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-017-0427-z     Document Type: Article

References (64)

1. Doig K, Papenfuss AT, Fox S. Clinical cancer genomic analysis: data engineering required. Lancet Oncol. 2015;16:1015-7. doi: 10.1016/S1470-2045(15)00195-3.
2. Wong SQ, Fellowes A, Doig K, Ellul J, Bosma TJ, Irwin D, et al. Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients. Br J Cancer. 2015;112:1411-20. doi: 10.1038/bjc.2015.80.
3. NATA. http://www.nata.com.au. Accessed 19 Apr 2017.
4. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra224. doi: 10.1126/scitranslmed.3007094.
5. Interactive_Biosoftware. Alamut Visual. 2016. http://www.interactive-biosoftware.com/alamut-visual/. Accessed 19 Apr 2017.
6. Agilent. Cartagenia. 2016. http://www.agilent.com/en-us/promotions/cartagenia-overview. Accessed 19 Apr 2017.
7. QIAGEN. CLC Genomics Workbench. 2016. https://www.qiagenbioinformatics.com/products/clc-genomics-workbench/. Accessed 19 Apr 2017.
8. QIAGEN. Ingenuity. 2016. https://www.qiagenbioinformatics.com/products/ingenuity-variant-analysis/. Accessed 19 Apr 2017.
9. Illumina. Variant Studio. 2016. http://www.illumina.com/informatics/research/biological-data-interpretation/variantstudio.html. Accessed 19 Apr 2017.
10. Aronson SJ, Clark EH, Babb LJ, Baxter S, Farwell LM, Funke BH, et al. The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testing. Hum Mutat. 2011;32:532-6. doi: 10.1002/humu.21470.
11. Hart SN, Duffy P, Quest DJ, Hossain A, Meiners MA, Kocher JP. VCF-Miner: GUI-based application for mining variants and annotations stored in VCF files. Brief Bioinform. 2016;17:346-51. doi: 10.1093/bib/bbv051.
12. Salatino S, Ramraj V. BrowseVCF: a web-based application and workflow to quickly prioritize disease-causative variants in VCF files. Brief Bioinform. 2016. doi: 10.1093/bib/bbw054.
13. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401-4. doi: 10.1158/2159-8290.CD-12-0095.
14. Zhou X, Edmonson MN, Wilkinson MR, Patel A, Wu G, Liu Y, et al. Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat Genet. 2016;48:4-6. doi: 10.1038/ng.3466.
15. Lawrence DM, Feng J, Schreiber AW, Geoghegan J. VariantGrid: Drag and Drop Variant Analysis. Poster at Australian Genomics Technologies Association Conference. Melbourne: 12-15 October 2014.
16. Tan PP, Rogic S, Zoubarev A, McDonald C, Liu F, Charathsandran G, et al. Interactive exploration, analysis and visualization of complex phenome-genome datasets with ASPIREdb. Hum Mutat. 2016;37:719-26. doi: 10.1002/humu.23011.
17. Zoubarev A, Hamer KM, Keshav KD, McCarthy EL, Santos JR, Van Rossum T, et al. Gemma: a resource for the reuse, sharing and meta-analysis of expression profiling data. Bioinformatics. 2012;28:2272-3. doi: 10.1093/bioinformatics/bts430.
18. Zhou W, Zhao H, Chong Z, Mark RJ, Eterovic AK, Meric-Bernstam F, et al. ClinSeK: a targeted variant characterization framework for clinical sequencing. Genome Med. 2015;7:34. doi: 10.1186/s13073-015-0155-1.
19. Canuel V, Rance B, Avillach P, Degoulet P, Burgun A. Translational research platforms integrating clinical and omics data: a review of publicly available solutions. Brief Bioinform. 2015;16:280-90. doi: 10.1093/bib/bbu006.
20. Servant N, Romejon J, Gestraud P, La Rosa P, Lucotte G, Lair S, et al. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial. Front Genet. 2014;5:152. doi: 10.3389/fgene.2014.00152.
21. Zhao Y, Polley EC, Li MC, Lih CJ, Palmisano A, Sims DJ, et al. GeneMed: an informatics hub for the coordination of next-generation sequencing studies that support precision oncology clinical trials. Cancer Inform. 2015;14:45-55. doi: 10.4137/CIN.S17282.
22. Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v. 2.0: the next generation in gene variant databases. Hum Mutat. 2011;32:557-63. doi: 10.1002/humu.21438.
23. Fokkema IF, den Dunnen JT, Taschner PE. LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach. Hum Mutat. 2005;26:63-8. doi: 10.1002/humu.20201.
24. Chung RH, Tsai WY, Kang CY, Yao PJ, Tsai HJ, Chen CH. FamPipe: an automatic analysis pipeline for analyzing sequencing data in families for disease studies. PLoS Comput Biol. 2016;12, e1004980. doi: 10.1371/journal.pcbi.1004980.
25. Paila U, Chapman BA, Kirchner R, Quinlan AR. GEMINI: integrative exploration of genetic variation and genome annotations. PLoS Comput Biol. 2013;9, e1003153. doi: 10.1371/journal.pcbi.1003153.
26. Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat Genet. 2017;49:170-174. doi: 10.1038/ng.3774.
27. Bean LJ, Tinker SW, da Silva C, Hegde MR. Free the data: one laboratory's approach to knowledge-based genomic variant classification and preparation for EMR integration of genomic data. Hum Mutat. 2013;34:1183-8. doi: 10.1002/humu.22364.
28. Roy S, Durso MB, Wald A, Nikiforov YE, Nikiforova MN. SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory. J Mol Diagn. 2014;16:11-22. doi: 10.1016/j.jmoldx.2013.08.005.
29. Tarczy-Hornoch P, Amendola L, Aronson SJ, Garraway L, Gray S, Grundmeier RW, et al. A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record. Genet Med. 2013;15:824-32. doi: 10.1038/gim.2013.120.
30. VCF Variant Call. Format http://www.1000genomes.org/wiki/Analysis/variant-call-format. Accessed 19 Apr 2017.
31. MariaDB. https://mariadb.org/. Accessed 19 Apr 2017.
32. Wong SQ, Li J, Vedururu R, Pang JM, Do H, Ellul J, et al. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genet. 2014;7:23. doi: 10.1186/1755-8794-7-23.
33. Tothill RW, Li J, Mileshkin L, Doig K, Siganakis T, Cowin P, et al. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary. J Pathol. 2013;231:413-23. doi: 10.1002/path.4251.
34. Parisot JP, Thorne H, Fellowes A, Doig K, Lucas M, McNeil JJ, et al. "Cancer 2015": a prospective, population-based cancer cohort-phase 1: Feasibility of genomics-guided precision medicine in the clinic. J Pers Med. 2015;5:354-69. doi: 10.3390/jpm5040354.
35. NA12878. https://catalog.coriell.org/0/Sections/Search/Sample_Detail.aspx?Ref=NA12878. Accessed 19 Apr 2017.
36. Bitbucket. https://confluence.atlassian.com/bitbucket. Accessed 19 Apr 2017.
37. Sadedin SP, Pope B, Oshlack A. Bpipe: a tool for running and managing bioinformatics pipelines. Bioinformatics. 2012;28:1525-6. doi: 10.1093/bioinformatics/bts167.
38. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat. 2008;29:6-13. doi: 10.1002/humu.20654.
39. Tan A, Abecasis GR, Kang HM. Unified representation of genetic variants. Bioinformatics. 2015;31:2202-4. doi: 10.1093/bioinformatics/btv112.
40. Mutalyzer. https://mutalyzer.nl/. Accessed 19 Apr 2017.
41. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010;26:2069-70. doi: 10.1093/bioinformatics/btq330.
42. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38, e164. doi: 10.1093/nar/gkq603.
43. Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10:1556-66. doi: 10.1038/nprot.2015.105.
44. Clinvitae. http://clinvitae.invitae.com. Accessed 19 Apr 2017.
45. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007;28:622-9. doi: 10.1002/humu.20495.
46. Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862-8. doi: 10.1093/nar/gkv1222.
47. Thorne H, Mitchell G, Fox S. kConFab: a familial breast cancer consortium facilitating research and translational oncology. J Natl Cancer Inst Monogr. 2011;2011:79-81. doi: 10.1093/jncimonographs/lgr042.
48. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43:D805-11. doi: 10.1093/nar/gku1075.
49. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, et al. The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008;Chapter 10:Unit 10.11. doi: 10.1002/0471142905.hg1011s57.
50. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011;39:D945-50. doi: 10.1093/nar/gkq929.
51. Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505:302-8. doi: 10.1038/nature12981.
52. Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014;20:682-8. doi: 10.1038/nm.3559.
53. FASTQC. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. Accessed 19 Apr 2017.
54. IGV. http://igv.org. Accessed 19 Apr 2017.
55. Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178-92. doi: 10.1093/bib/bbs017.
56. JIRA. http://www.atlassian.com/software/jira. Accessed 19 Apr 2017.
57. BIC BRCA LSDB https://research.nhgri.nih.gov/bic/. Accessed 19 Apr 2017.
58. IARC P53 LSDB http://p53.iarc.fr/DownloadDataset.aspx. Accessed 19 Apr 2017.
59. Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, et al. Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014;311:1035-45. doi: 10.1001/jama.2014.1717.
60. Groovy. http://www.groovy-lang.org. Accessed 19 Apr 2017.
61. Grails. http://grails.org. Accessed 19 Apr 2017.
62. Children's Cancer Institute https://ccia.org.au/. Accessed 19 Apr 2017.
63. GNU General Public License. https://www.gnu.org/licenses/gpl.html. Accessed 19 Apr 2017.
64. VM Virtual Box https://www.virtualbox.org/. Accessed 19 Apr 2017.